India to spend 100 billion rupees to make biopharma production hub
The funding will be directed towards the research and production of biologics and biosimilar medicines India will invest 100 billion…
Tag
The funding will be directed towards the research and production of biologics and biosimilar medicines India will invest 100 billion…
The group intends to raise at least S$5 million from the exercise, with new shares issued at S$0.10 apiece Singapore-based speciality…
The placement price represents a discount of 9.7% to the volume weighted average price (VWAP) of S$0.1107 per share Mainboard-listed iX…
The placement price represents a discount of 9.7% to the volume weighted average price (VWAP) of S$0.1107 per share Mainboard-listed iX…
Shares of Singapore-based speciality pharmaceutical and nutraceutical company iX Biopharma jumped 35.1 per cent to S$0.127 on Monday (Oct…
France’s Sanofi has agreed to buy US-based Blueprint Medicines Corporation for up to US$9.5 billion to boost its position in rare…
Patients are flocking to the region in search of good quality, alternative healthcare treatments, while biopharma firms are making forays…